You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Massachusetts General Hospital (MGH) has a history of excellence and is internationally recognized as a world class medical center, providing quality medical care, advancing medicine through clinical and laboratory research and facilitating the education of exceptional health care professionals. The Massachusetts General Hospital Radiation Oncology Department, staff, residents and fellows, past and present, concur that MGH stands for Man’s Greatest Hospital. This decidedly immodest assessment is widely viewed amongst this group as being manifestly true, and that perception is clearly reflected in a marvelous esprit de corp. Such an unequivocally positive attitude is solidly based on th...
Cancer therapeutics include an ever-increasing array of tools at the disposal of clinicians in their treatment of this disease. However, cancer is a tough opponent in this battle, and current treatments, which typically include radiotherapy, chemotherapy and surgery, are not often enough to rid the patient of his or her cancer. Cancer cells can become resistant to the treatments directed at them, and overcoming this drug resistance is an important research focus. Additionally, increasing discussion and research is centering on targeted and individualized therapy. While a number of approaches have undergone intensive and close scrutiny as potential approaches to treat and kill cancer (signali...
Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionall...
The sixth edition of this internationally successful text includes the many positive advances in radiation oncology that have occurred over the past decade, and which continue to keep radiation at the cutting edge of cancer therapy. As previously, a multi-national authorship includes some of the top radiation oncologists, biologists, and physicists from North America and Europe, who highlight the core principles of radiobiology.
Human Radiation Injury is a concise but thorough presentation of known toxicities of radiation exposure in humans. This unique text is the only single reference available that studies the risks to humans from medical, environmental, and accidental or terrorist-related exposure to radiation. The chapters cover modern understanding of the molecular and cellular events involved in radiation injury, the known dose-effect relationships for human organ systems, and a full discussion of normal tissue toxicity related to therapeutic radiation. Recommended guidelines are outlined and the best available treatments following injury are also detailed. A companion website offers the fully searchable text and an image bank.
This issue of the Surgical Oncology Clinics of North America, Guest Edited by Dr. Greg Masters, will highlight the multi-disciplinary approach to a variety of common malignancies, focusing on how surgical oncologists work together with medical oncologists and radiation oncologists to provide the most up-to-date management for many different malignancies. It will focus on the latest data from updates in basic science and clinical trials, including the importance of new technology and surgical techniques, new radiation techniques and the latest in chemotherapy, biologic, and targeted drug development in the multidisciplinary care of cancer patients.
High-energy charged particles represent a cutting-edge technique in radiation oncology. Protons and carbon ions are used in several centers all over the world for the treatment of different solid tumors. Typical indications are ocular malignancies, tumors of the base of the skull, hepatocellular carcinomas and various sarcomas. The physical characteristics of the charged particles (Bragg peak) allow sparing of much more normal tissues than it is possible using conventional X-rays, and for this reason all pediatric tumors are considered eligible for protontherapy. Ions heavier than protons also display special radiobiological characteristics, which make them effective against radioresistant a...
This issue of Hematology/Oncology Clinics, Guest Edited by Drs. Ravi A. Chandra, Lisa A. Kachnic, Charles R. Thomas, Jr., is part one of a two-part issue focused on Contemporary Topics in Radiation Medicine. Topics include, but are not limited to, Basic Medical Physics, Basic Radiobiology, Modern Radiation Treatment Planning & Delivery, Advanced Imaging Techniques in Diagnosis and Tx, Particle Therapy/Protons, SRS/SBRT, Modern Brachytherapy, Immunotherapy/Abscopal, Nanotechnology, Bioinformatics & Artificial Intelligence, Quality-of-life & Outcomes, Normal Tissue Issues and Toxicity, Radiation Modifiers, and Health Economics/Disparities.
None